Gene therapies to reduce chronic pain: are we there yet?
Pain Manag
.
2020 Jul;10(4):209-212.
doi: 10.2217/pmt-2020-0021.
Epub 2020 Jun 17.
Authors
Andrea Vega-Loza
1
,
Christina Van
1
,
Ana M Moreno
1
,
Fernando Aleman
1
Affiliation
1
Navega Therapeutics, 3210 Merryfield Row, San Diego, CA 92121, USA.
PMID:
32677877
DOI:
10.2217/pmt-2020-0021
No abstract available
Keywords:
CRISPR; NaV1.7; chronic pain; gene therapy; pain management; precision medicine.
Publication types
Editorial
MeSH terms
Chronic Pain / genetics
Chronic Pain / therapy*
Genetic Therapy*
Humans
Pain Management*
Precision Medicine*
Grants and funding
R43 CA239940/CA/NCI NIH HHS/United States
U44 NS122114/NS/NINDS NIH HHS/United States